GHP October 2016

ghp Research, Translation, Commercialisation inside this issue this month’s feature editor’s note “Providing the opportunity for people to live life to the fullest is a lot of what we do, and a life to the fullest is a life with as little pain as possible, regardless of how long that life will be.” Clare Periton, CEO Helen & Douglas House Living and Dying in Pain: Why a Person’s Death Should Not Be Painful We spoke to Clare Periton, CEO of Helen & Douglas House who explains to us how recent evidence shows that some people who receive palliative care can live for longer. Page 10 04 News Health & Social Care 10 Living and Dying in Pain: Why a Person’s Death Should Not Be Painful 12 Know the Drill 14 High-End Specialist Residential Nursing Care 16 A Complementary and Integrative Approach to Better Health 18 Collaborative, ‘Whole Person’ Health Care 20 The World’s Leading Authority on Cancer Prevention Research Innovation & Technology 22 Collaborations between Pharma and Diag- nostic Companies Boost Growth for Neurodiagnostics 24 Visualising Success Research & Development 26 Full Genomic Sequencing of Zika Could Help Unlock Virus’s Secrets Translation & Commercialisation 28 Morocco, Poland and Vietnam Earmarked for Financial growth Educatrion & Skills 30 Overseas Doctors Welcome in Scotland 31 Winners’ Directory Deals 32 Deals Global Health & Pharma, Floor 1, Suite F, The Maltsters, 1-2 Wetmore Road, Burton On Trent, Staffordshire, DE14 1LS Tel: +44 (0) 1234 567 890 | Email: [email protected] | Web: Welcome to the October edition of Global Health & Pharma, includes the latest news, alongside a variety of exciting features, including a special guest article from the world’s first children’s hospice on why having access to palliative care is something that every person deserves. Helen & Douglas House’s CEO Clare Periton goes on to say that advances in technology and medication have enabled drugs to be much subtler now. This progression is invaluable in the sector she believes, and is especially helpful when caring for children and young adults, as they do at Helen & Douglas House. In addition to a major focus on health & social care, we also feature an insightful section covering innovation and technology. One contributor, Joost Bakker of Scicomvisuals, says that the biotechnology sector provides a truly dynamic environment in which goal-oriented science and bright ideas can flourish. Alongside this, he says that it takes remarkable acumen and drive to excel in this field, which is crucial to develop solutions that really help to deal with the challenges of today. In research and development news, the Medical Research Council reveals that scientists have been able to shed more light on how the Zika virus works, by sequencing the full-length genome of the virus from a patient in Brazil and studying how a molecule derived from the genome fights the host antiviral response. I hope that you enjoy reading this absorbing edition. Jonathan Miles, Editor